Share class: Diaceutics PLC

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A185,331,78061,399,069 ( 71.95 %) 252,063 ( 0.2954 %) 71.95 %

Major shareholders: Diaceutics PLC

NameStocks%Valuation
Gresham House Asset Management Ltd. (Investment Management)
13.54 %
11,502,591 13.54 % 22 M p
Canaccord Genuity Wealth Ltd.
6.156 %
5,227,414 6.156 % 10 M p
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
4.722 %
4,009,764 4.722 % 8 M p
Gresham House Asset Management Ltd.
4.54 %
3,855,155 4.54 % 7 M p
TrinityBridge Ltd.
3.818 %
3,242,000 3.818 % 6 M p
BlackRock Investment Management (UK) Ltd.
3.196 %
2,714,165 3.196 % 5 M p
West Elk Capital LLC
2.995 %
2,543,281 2.995 % 5 M p
Danske Bank A/S (Investment Management)
2.988 %
2,537,612 2.988 % 5 M p
Maven Capital Partners UK LLP
2.877 %
2,442,960 2.877 % 5 M p
Octopus Investments Ltd.
2.826 %
2,400,020 2.826 % 5 M p
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional56.24%
Individuals0.1%
Unknown43.66%

Based on 1000 largest holdings

Geographical origin of shareholders

United Kingdom
43.28%
Germany
5.77%
United States
2.99%
Denmark
2.99%
Thailand
0.61%
Netherlands
0.6%
Individuals
0.1%

Based on 1000 largest holdings

Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205